ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,631.22
      0.28%
      US Tech 100
      19,886.80
      0.21%
      Dow Jones
      40,211.72
      0.00%
      Brent Oil
      82.945
      -1.65%
      Bitcoin
      63,702.02
      -1.77%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Vertex Pharmaceuticals Inc (VRTX)

      7. Vertex Pharmaceuticals Inc (VRTX) News

      VRTX

      Vertex Pharmaceuticals (VRTX)

      Vertex Pharmaceuticals Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:VRTX
      DateTimeSourceHeadlineSymbolCompany
      04/01/20226:17AMTipRanksH.C. Wainwright Believes Vertex Pharmaceuticals (VRTX) Still Has Room to GrowNASDAQ:VRTXVertex Pharmaceuticals Inc
      03/31/20222:55PMTipRanksAnalysts’ Opinions Are Mixed on These Healthcare Stocks: Outlook Therapeutics (OTLK) and Vertex Pharmaceuticals (VRTX)NASDAQ:VRTXVertex Pharmaceuticals Inc
      03/31/20229:00AMDow Jones NewsVertex Pharmaceuticals to Advance VX-548 Pain Drug After Positive Phase 2 StudiesNASDAQ:VRTXVertex Pharmaceuticals Inc
      03/31/20228:00AMBusiness WireVertex Announces Statistically Significant and Clinically Meaningful Results From Two Phase 2 Proof-of-Concept Studies of VX-548 for the Treatment of Acute PainNASDAQ:VRTXVertex Pharmaceuticals Inc
      03/26/20225:00PMBusiness WireVertex Announces Reimbursement Agreement in Australia for TRIKAFTA® (elexacaftor/tezacaftor/ivacaftor and ivacaftor) for Patients With Cystic Fibrosis Ages 12 Years and Older With at Least One F508del Mutation in the CFTR GeneNASDAQ:VRTXVertex Pharmaceuticals Inc
      03/25/20228:00AMPR Newswire (Canada)L'autorisation de mise en marché de KALYDECO® (ivacaftor) est accordée par Santé Canada pour les patients atteints de fibrose kystique âgés de 4 mois à 18 ans porteurs de la mutation R117H du gène CFTRNASDAQ:VRTXVertex Pharmaceuticals Inc
      03/25/20228:00AMPR Newswire (Canada)Health Canada Grants Marketing Authorization for KALYDECO® (ivacaftor) for Patients With Cystic Fibrosis Between the Ages of 4 Months and 18 Years With the R117H Mutation in the CFTR GeneNASDAQ:VRTXVertex Pharmaceuticals Inc
      03/24/202210:56AMTipRanksAnalysts Offer Insights on Healthcare Companies: Halozyme (HALO), Vertex Pharmaceuticals (VRTX) and Relmada Therapeutics (RLMD)NASDAQ:VRTXVertex Pharmaceuticals Inc
      03/23/20227:45AMTipRanksAnalysts’ Top Healthcare Picks: Vertex Pharmaceuticals (VRTX), Argenx Se (ARGX)NASDAQ:VRTXVertex Pharmaceuticals Inc
      03/23/20226:15AMTipRanksAnalysts Are Bullish on Top Healthcare Stocks: Arrowhead Pharmaceuticals (ARWR), Vertex Pharmaceuticals (VRTX)NASDAQ:VRTXVertex Pharmaceuticals Inc
      03/22/20228:00AMBusiness WireVertex Advances VX-147 Into Pivotal Clinical Development for People With APOL1-Mediated Kidney DiseaseNASDAQ:VRTXVertex Pharmaceuticals Inc
      03/21/20224:16PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:VRTXVertex Pharmaceuticals Inc
      03/21/20224:13PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:VRTXVertex Pharmaceuticals Inc
      03/14/20229:08AMTipRanksVertex Pharmaceuticals (VRTX) Gets a Buy Rating from H.C. WainwrightNASDAQ:VRTXVertex Pharmaceuticals Inc
      03/03/20229:25AMTipRanksVertex Pharma: On Track for Growth InvestorsNASDAQ:VRTXVertex Pharmaceuticals Inc
      03/01/20224:05PMBusiness WireVertex to Present at Cowen’s 42nd Annual Health Care Conference on March 8NASDAQ:VRTXVertex Pharmaceuticals Inc
      02/28/20226:09PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:VRTXVertex Pharmaceuticals Inc
      02/28/20226:08PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:VRTXVertex Pharmaceuticals Inc
      02/28/20226:01PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:VRTXVertex Pharmaceuticals Inc
      02/28/20225:53PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:VRTXVertex Pharmaceuticals Inc
      02/28/20225:52PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:VRTXVertex Pharmaceuticals Inc
      02/28/20225:43PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:VRTXVertex Pharmaceuticals Inc
      02/22/20225:06PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:VRTXVertex Pharmaceuticals Inc
      02/22/20225:06PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:VRTXVertex Pharmaceuticals Inc
      02/22/20225:04PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:VRTXVertex Pharmaceuticals Inc
      02/22/20225:03PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:VRTXVertex Pharmaceuticals Inc
      02/22/20225:01PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:VRTXVertex Pharmaceuticals Inc
      02/22/20224:56PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:VRTXVertex Pharmaceuticals Inc
      02/16/20224:06PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:VRTXVertex Pharmaceuticals Inc
      02/14/20225:16PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:VRTXVertex Pharmaceuticals Inc
       Showing the most relevant articles for your search:NASDAQ:VRTX